Company hopes test will revolutionize autism diagnosis, treatment

Madison stem cell research company Stemina Biomarker Discovery plans to introduce a metabolism-based autism blood test to the public in 2017. "What we hope this will do is revolutionize the way we diagnose and treat autism, so that we can both diagnose sooner and focus treatment," Stemina CEO Beth Donley said.

http://ift.tt/1xEF2JC